Accessibility Menu
 

Acrux

(OTC) ARUXF

Current Price$0.00
Market Cap$1.85M
Since IPO (2008)-100%
5 Year-97%
1 Year-85%
1 Month-52%

Acrux Financials at a Glance

Market Cap

$1.85M

Revenue (TTM)

$3.61M

Net Income (TTM)

$8.34M

EPS (TTM)

$-0.00

P/E Ratio

-1.22

Dividend

$0.00

Beta (Volatility)

-0.71 (Low)

Price

$0.00

Volume

6,025

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

ARUXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acrux

Industry

Pharmaceuticals

CEO

John Warmbrunn

Headquarters

West Melbourne, VIC 3003, AU

ARUXF Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-2%

Net Income Margin

-84%

Return on Equity

-102%

Return on Capital

-2%

Return on Assets

-50%

Earnings Yield

-81.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.85M

Shares Outstanding

410.61M

Volume

6.03K

Avg. Volume

0

Financials (TTM)

Gross Profit

$1.19M

Operating Income

$8.97M

EBITDA

$5.17M

Operating Cash Flow

$5.47M

Capital Expenditure

$5.00K

Free Cash Flow

$5.48M

Cash & ST Invst.

$863.00K

Total Debt

$3.63M

Acrux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.74M

-60.6%

Gross Profit

$1.52M

+166.7%

Gross Margin

87.24%

N/A

Market Cap

$1.85M

N/A

Market Cap/Employee

$42.97K

N/A

Employees

43

N/A

Net Income

$164.93K

+105.1%

EBITDA

$1.07M

+73.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.69M

-216.8%

Accounts Receivable

$1.63M

-58.6%

Inventory

$0.00

N/A

Long Term Debt

$2.88M

+47.5%

Short Term Debt

$755.70K

+147.8%

Return on Assets

-49.76%

N/A

Return on Invested Capital

-1.94%

N/A

Free Cash Flow

$1.53M

+197.2%

Operating Cash Flow

$1.53M

+207.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AXIMAXIM Biotechnologies, Inc.
$0.01+20.00%
PKTXProtoKinetix, Incorporated
$0.01+0.00%
SIGYSigyn Therapeutics, Inc.
$0.04-9.09%
REPCFRepliCel Life Sciences Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
RXTRackspace Technology
$5.49+0.56%
IRENIren
$61.20+0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.62+0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$76.28+0.07%

Questions About ARUXF

What is the current price of Acrux?

Acrux is trading at $0.00 per share.

What is the 52-week range for Acrux?

Over the past 52 weeks, Acrux has traded between $0.00 and $0.05.

How much debt does Acrux have?

As of the most recent reporting period, Acrux reported total debt of $2.38M.

How much cash does Acrux have on hand?

Acrux reported $565,567.05 in cash and cash equivalents in its most recent financial results.

What is Acrux’s dividend yield?

Acrux does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.